MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2147-2156

  Leung, Chung Man ^a,b   Chen, Ting Wen ^c   Li, Sung Chou ^d   Ho, Meng Ru ^e   Hu, Ling Yueh ^f   Liu, Wen Shan ^a   Wu, Tony T ^a,g   Hsu, Ping Chi ^b   Chang, Hong Tai ^a   Tsai, Kuo Wang ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e BIODIVERSITY RESEARCH CENTER   (Taiwan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; MicroRNA; MiR 17 92 cluster; Next generation sequencing; Pathway enrichment analysis; Radiation; TCGA

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 17; MICRORNA 18A; MICRORNA 19A; MICRORNA 19B; MICRORNA 20A; MICRORNA 92A; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE FRACTIONATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84898640684     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3089     Document Type: Article

References (57)

1. Delaney G, Jacob S, Featherstone C and Barton M: The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104: 1129-1137, 2005
2. Rzeszowska-Wolny J, Przybyszewski WM and Widel M: Ionizing radiation-induced bystander effects, potential targets for modulation of radiotherapy. Eur J Pharmacol 625: 156-164, 2009
3. Runkle EA, Zhang H, Cai Z, et al: Reversion of the ErbB malignant phenotype and the DNA damage response. Exp Mol Pathol 93: 324-333, 2012
4. Yin E, Nelson DO, Coleman MA, Peterson LE and Wyrobek AJ: Gene expression changes in mouse brain after exposure to low-dose ionizing radiation. Int J Radiat Biol 79: 759-775, 2003
5. Correa CR and Cheung VG: Genetic variation in radiation-induced expression phenotypes. Am J Hum Genet 75: 885-890, 2004
6. Tsai MH, Cook JA, Chandramouli GV, et al: Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 67: 3845-3852, 2007
7. John-Aryankalayil M, Palayoor ST, Cerna D, et al: Fractionated radiation therapy can induce a molecular profile for therapeutic targeting. Radiat Res 174: 446-458, 2010
8. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004
9. Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610, 2010
10. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005
11. Guo X, Wu Y and Hartley RS: MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol 6: 575-583, 2009
12. Ma L, Teruya-Feldstein J and Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688, 2007
13. Wang L, Yuan C, Lv K, et al: Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling. PLoS One 8: E67373, 2013
14. Lee KM, Choi EJ and Kim IA: MicroRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiother Oncol 101: 171-176, 2011
15. Lin J, Liu C, Gao F, et al: MiR-200c enhances radiosensitivity of human breast cancer cells. J Cell Biochem 114: 606-615, 2013
16. Anastasov N, Höfig I, Vasconcellos IG, et al: Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells. Radiat Oncol 7: 206, 2012
17. Yi H, Liang B, Jia J, et al: Differential roles of miR-199a-5p in radiation-induced autophagy in breast cancer cells. FEBS Lett 587: 436-443, 2013
18. Körner C, Keklikoglou I, Bender C, Wörner A, Münstermann E, and Wiemann S: MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C ? (PKC?). J Biol Chem 288: 8750-8761, 2013
19. Cloonan N, Wani S, Xu Q, et al: MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol 12: R126, 2011
20. John-Aryankalayil M, Palayoor ST, Makinde AY, et al: Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res 178: 105-117, 2012
21. Ebhardt HA, Tsang HH, Dai DC, Liu Y, Bostan B and Fahlman RP: Meta-analysis of small RNA-sequencing errors reveals ubiquitous post-transcriptional RNA modifications. Nucleic Acids Res 37: 2461-2470, 2009
22. Landgraf P, Rusu M, Sheridan R, et al: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414, 2007
23. Reid JG, Nagaraja AK, Lynn FC, et al: Mouse let-7 miRNA populations exhibit RNA editing that is constrained in the 5'-seed/cleavage/anchor regions and stabilize predicted mmu-let-7a:mRNA duplexes. Genome Res 18: 1571-1581, 2008
24. Morin RD, O'Connor MD, Griffith M, et al: Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 18: 610-621, 2008
25. Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: E179, 2005
26. Li C, Li X, Miao Y, et al: SubpathwayMiner: A software package for flexible identification of pathways. Nucleic Acids Res 37: E131, 2009
27. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005
28. Hayashita Y, Osada H, Tatematsu Y, et al: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005
29. Cho WC: OncomiRs: The discovery and progress of microRNAs in cancers. Mol Cancer 6: 60, 2007
30. Pan HW, Li SC and Tsai KW: MicroRNA dysregulation in gastric cancer. Curr Pharm Des 19: 1273-1284, 2013
31. Zhao L, Bode AM, Cao Y and Dong Z: Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis 33: 2220-2227, 2012
32. Chang HT, Li SC, Ho MR, et al: Comprehensive analysis of microRNAs in breast cancer. BMC Genomics 13 (Suppl 7): S18, 2012
33. Ferracin M, Querzoli P, Calin GA and Negrini M: MicroRNAs: Toward the clinic for breast cancer patients. Semin Oncol 38: 764-775, 2011
34. Ng EK, Wong CL, Ma ES and Kwong A: MicroRNAs as new players for diagnosis, prognosis, and therapeutic targets in breast cancer. J Oncol 2009: 305420, 2009
35. Iorio MV, Casalini P, Piovan C, Braccioli L and Tagliabue E: Breast cancer and microRNAs: Therapeutic impact. Breast 20 (Suppl 3): S63-S70, 2011
36. Camps C, Buffa FM, Colella S, et al: Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348, 2008
37. Kovalchuk O, Filkowski J, Meservy J, et al: Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 7: 2152-2159, 2008
38. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008
39. Si H, Sun X, Chen Y, et al: Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol 139: 223-229, 2013
40. Zhao L, Lu X and Cao Y: MicroRNA and signal transduction pathways in tumor radiation response. Cell Signal 25: 1625-1634, 2013
41. Weidhaas JB, Babar I, Nallur SM, et al: MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67: 11111-11116, 2007
42. Liang Z, Ahn J, Guo D, Votaw JR and Shim H: MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation. Pharm Res 30: 1008-1016, 2013
43. de Rinaldis E, Gazinska P, Mera A, et al: Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control. BMC Genomics 14: 643, 2013
44. Kim K, Chadalapaka G, Lee SO, et al: Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 31: 1034-1044, 2012
45. Li H, Bian C, Liao L, Li J and Zhao RC: MiR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat 126: 565-575, 2011
46. Jiang P, Rao EY, Meng N, Zhao Y and Wang JJ: MicroRNA-17-92 significantly enhances radioresistance in human mantle cell lymphoma cells. Radiat Oncol 5: 100, 2010
47. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495, 1992
48. Simone CB II, John-Aryankalayil M, Palayoor ST, et al: MRNA expression profiles for prostate cancer following fractionated irradiation are influenced by p53 status. Transl Oncol 6: 573-585, 2013
49. Yan HL, Xue G, Mei Q, et al: Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J 28: 2719-2732, 2009
50. Thomas M, Lange-Grunweller K, Hartmann D, et al: Analysis of transcriptional regulation of the human miR-17-92 cluster; evidence for involvement of Pim-1. Int J Mol Sci 14: 12273-12296, 2013
51. Li Y, Li Y, Zhang H and Chen Y: MicroRNA-mediated positive feedback loop and optimized bistable switch in a cancer network involving miR-17-92. PLoS One 6: E26302, 2011
52. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A and Marsh CB: MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 105: 19678-19683, 2008
53. Papanikolaou V, Iliopoulos D, Dimou I, et al: Survivin regulation by HER2 through NF-?B and c-myc in irradiated breast cancer cells. J Cell Mol Med 15: 1542-1550, 2011
54. Orr MS, Watson NC, Sundaram S, Randolph JK, Jain PT and Gewirtz DA: Ionizing radiation and teniposide increase p21waf1/cip1 and promote Rb dephosphorylation but fail to suppress E2F activity in MCF-7 breast tumor cells. Mol Pharmacol 52: 373-379, 1997
55. Calaf GM and Hei TK: Ionizing radiation induces alterations in cellular proliferation and c-myc, c-jun and c-fos protein expression in breast epithelial cells. Int J Oncol 25: 1859-1866, 2004
56. Wang Y, Huang JW, Li M, et al: MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol Cancer Res 9: 1100-1111, 2011
57. Niemoeller OM, Niyazi M, Corradini S, et al: MicroRNA expression profiles in human cancer cells after ionizing radiation. Radiat Oncol 6: 29, 2011